BCR and B-cell chronic lymphocytic leukemia: Growth and anti-apoptotic signals from the B cell receptor (BCR) along with chemokine- and toll-like-receptors (TLRs) are delivered to CLL cells in lymphoid organ microenvironments called proliferation centers (PCs) through pathways that involve BTK and are blocked by ibrutinib (7).